why choose us

First received: August 25, 2023

Clinical Trial: A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme

Study Status: Completed

Recruit Status: RECRUITING

Condition: Fabry's Disease

Study Type: INTERVENTIONAL


Official Title: A Study to Investigate Safety and Tolerability of Higher Infusion Rate to shORten the duraTion of FabrazymE Infusion

Brief Summary: This Phase 4 study will evaluate the safety and tolerability of Fabrazyme at current approved dose with increases in the infusion rate and reduced infusion volume.This study aims to generate data to provide the guidance on how infusion rate can be safely increased and minimize the burden of the life-long treatment with Fabrazyme.

Read more